Sylvant (siltuximab)

pCPA File Number: 20842
Negotiation Status:
Concluded with an LOI
Indication(s):
Multicentric Castleman's Disease (MCD)
Sponsor/Manufacturer:
Janssen Inc.
CDA-AMC Project Number:
PC0052-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: